Skip to main content

Flora Growth Settles Convertible Note with DeFi Development

Tipranks - Thu Jan 1, 4:00PM CST

Claim 70% Off TipRanks This Holiday Season

An update from Flora Growth ( (FLGC) ) is now available.

On December 29, 2025, Flora Growth Corp. entered into a note settlement agreement with DeFi Development Corp. to fully satisfy a Solana-denominated convertible note originally issued under a September 19, 2025 securities purchase agreement. Under the settlement, Flora agreed to pay 96.161907647528 Solana, US$1.75 million in cash and issue 111,550 common shares valued at US$6.90 per share by January 6, 2026, after which the note’s principal and interest would be deemed paid in full, all obligations under the note extinguished, and both parties mutually released from any related claims, with the settlement shares issued under an exemption from U.S. securities registration requirements.

The most recent analyst rating on (FLGC) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Flora Growth stock, see the FLGC Stock Forecast page.

Spark’s Take on FLGC Stock

According to Spark, TipRanks’ AI Analyst, FLGC is a Neutral.

The score is held down primarily by deteriorating financial performance (declining revenue, ongoing losses, higher leverage and shrinking equity) and a strongly bearish technical setup (price below all key moving averages with negative MACD). Corporate event news provides some liquidity/strategic support, but valuation is hard to assess given negative earnings and no dividend data.

To see Spark’s full report on FLGC stock, click here.

More about Flora Growth

Flora Growth Corp. operates in the financial and digital asset investment sphere, engaging in structured financing arrangements that can include cryptocurrency-denominated instruments such as Solana-based convertible notes, alongside equity and cash components.

Average Trading Volume: 38,083

Technical Sentiment Signal: Sell

Current Market Cap: $5.15M

See more insights into FLGC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.